inTEST reported strong Q2 2021 financial results, with net revenues exceeding guidance, increasing 12% sequentially and 64% year-over-year. GAAP EPS increased to $0.24, and non-GAAP adjusted net earnings per diluted share reached $0.27, at the high-end of guidance.
Net revenues of $21.8 million exceeded guidance, with a 12% sequential increase and a 64% year-over-year increase.
GAAP earnings per share of $0.24 increased sequentially and year-over-year.
Non-GAAP adjusted net earnings per diluted share was $0.27, at the high-end of guidance.
Company is investing in growth opportunities outside of the semiconductor market, such as electric vehicles, cannabis, and the medical market.
inTEST expects net revenues for the 2021 third quarter to be in the range of $20.5 million to $21.5 million. On a GAAP basis, net earnings per diluted share will range from $0.18 to $0.22. On a non-GAAP basis, adjusted net earnings per diluted share will range from $0.21 to $0.25. Gross margin is expected to range from 49% to 51%.